Table 2. mab-5; spon-1 double mutant analysis.
| AQR position (%) | PQR position (%) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Genotype | 1 | 2 | 3 | 4 | 5 | N | 1 | 2 | 3 | 4 | 5 | N |
| spon-1(e2623) | 98 | 1 | 1 | 0 | 0 | 158 | 0 | 1 | 0 | 1 | 98 | 159 |
| mab-5(e2088) | 100 | 0 | 0 | 0 | 0 | 249 | 96 | 2 | 1 | 0 | 1 | 249 |
| mab-5(e2088); spon-1(e2623) | 100 | 0 | 0 | 0 | 0 | 146 | 87 | 9 | 2 | 2 | 0 | 249 |
| mab-5(e1239) | 99 | 1 | 0 | 0 | 0 | 283 | 99 | 1 | 0 | 0 | 0 | 283 |
| mab-5(e1239); spon-1(e2623) | 97 | 2 | 0 | 0 | 1 | 316 | 92 | 3 | 3 | 1 | 1 | 316 |
| mab-5(bx54) | 100 | 0 | 0 | 0 | 0 | 161 | 86 | 11 | 2 | 1 | 0 | 161 |
| mab-5(bx54); spon-1(e2623) | 88* | 7 | 5 | 1 | 0 | 176 | 80 | 13 | 5 | 1 | 2 | 176 |
| mab-5(mu114) | 100 | 0 | 0 | 0 | 0 | 202 | 83 | 11 | 4 | 0 | 1 | 202 |
| mab-5(mu114); spon-1(e2623) | 89* | 9 | 0 | 0 | 0 | 226 | 72 | 20 | 7 | 0 | 0 | 225 |
*
P < 0.05 compared to corresponding additive effect (not tested for PQR).